Professor Douglas Kell's blog: news from our Chief Executive

Tag: pharmaceuticals

A visit to Taiwan

Following the signing of a Memorandum of Understanding between the Taiwanese National Science Council and BBSRC last November, I was very pleased to have the opportunity to visit Taiwan last week, necessarily for a short but very intense, useful and enjoyable programme.

The first port of call was the College of Life Sciences of the National Taiwan University in Taipei where I was able to speak with a good number of the Faculty and also gave a talk about BBSRC’s funding models, as well as an academic seminar to a full (and evidently well-informed) house on the cellular uptake of pharmaceutical drugs.
Continue reading: A visit to Taiwan

A very full week last week (ok, they are all ‘full’) started with the visit of Minister of Universities and Science David Willetts to a topping out ‘milestones’ ceremony celebrating partial completion of the ‘Development Phase 1’ building at the Institute for Animal Health at Pirbright. This is a major project for us, with this part alone costing rather north of £100M. It will allow a major expansion of our abilities to carry out research in this space, and will surely prove a magnet to other talented researchers. For reasons of biosecurity, the building itself includes many technical innovations, as well as high specifications even for more conventional materials like the concrete of which it is constructed. This kind of infrastructure is paralleled by e-infrastructure, another important part of scientific infrastructure for the development of which I attended another meeting.
Continue reading: Animal health, Eisai, institutes and infrastructure

Last week was a truncated post-Bank Holiday week, mainly with internal meetings. One of these involved a very useful visit to JBOS, the (BBSRC-hosted) Joint Building and Office Services looks after both the physical structure of Polaris House in Swindon as well as many common services such as the switchboard, the Post Room (> 7000 items per day…), catering and the like. It is often easy to forget such infrastructures (except when things don’t work), and so it was nice to meet the folk who look after us in this way.

We had another meeting of the ‘Pharmaceutical Forum’, a group that brings the Chief Executives of BBSRC, EPSRC and MRC together with senior representatives of the Pharmaceutical Industry.
Continue reading: JBOS, e-infrastructure and pharmaceuticals

Summer, cricket and Bayes

This week the blog and I are officially on holiday, which allows me to enjoy a few of my hobbies such as following the cricket via the splendid Cricinfo and the evening highlights programme (it is nice finally to see the England cricket team number one in the world, just like the UK’s biologists). I have also been catching up on my reading (including via my new ownership of a tablet computer that runs the free Kindle app).

I have much enjoyed reading a popular book on the history of Bayes’ rule; it is extremely well written, and makes the story thoroughly gripping, as indeed it is. I am an increasing fan of the Bayesian approach, and I am writing something about it over the summer. I also read a handy little book on Matrix Management, and (with computer simulation occupying a philosophically uncertain position between ‘theory’ and ‘experiment’) one on the epistemology of computer simulations.
Continue reading: Summer, cricket and Bayes

ATPs, Roslin and Pharma

As a one-time bioenergeticist, ATP usually means adenosine triphosphate, a so-called high-energy phosphate compound used as a means of storing chemical potential (i.e. free energy) in cells. In the present case, however, it means our Advanced Training Partnerships, that were recently announced, and last week I formally signed off some of the grant announcement letters themselves. The ATPs have been cleverly designed, with extensive stakeholder engagement, to ensure that they really will deliver training shaped to the needs of users, and are an exciting new part of our delivery.

I also led the latest quarterly talk to all BBSRC (and BBSRC-hosted) staff based in Polaris House. These talks always include a pot-pourri of topics, and this one included a presentation by BBSRC’s Louisa Jenkin of activities in our third core theme of Basic Bioscience Underpinning Health, not least our programme in the biology of healthy ageing – a topic that is probably of universal interest.
Continue reading: ATPs, Roslin and Pharma